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Abstract
Background: Human height is a classical example of a polygenic quantitative trait. Recent large-scale genome-wide
association studies (GWAS) have identified more than 200 height-associated loci, though these variants explain only 2,10%
of overall variability of normal height. The objective of this study was to investigate the variance explained by these loci in a
relatively isolated population of European descent with limited admixture and homogeneous genetic background from the
Adriatic coast of Croatia.
Methodology/Principal Findings: In a sample of 1304 individuals from the island population of Hvar, Croatia, we performed
genome-wide SNP typing and assessed the variance explained by genetic scores constructed from different panels of
height-associated SNPs extracted from five published studies. The combined information of the 180 SNPs reported by
Lango Allen el al. explained 7.94% of phenotypic variation in our sample. Genetic scores based on 20,50 SNPs reported by
the remaining individual GWA studies explained 3,5% of height variance. These percentages of variance explained were
within ranges comparable to the original studies and heterogeneity tests did not detect significant differences in effect size
estimates between our study and the original reports, if the estimates were obtained from populations of European
descent.
Conclusions/Significance: We have evaluated the portability of height-associated loci and the overall fitting of estimated
effect sizes reported in large cohorts to an isolated population. We found proportions of explained height variability were
comparable to multiple reference GWAS in cohorts of European descent. These results indicate similar genetic architecture
and comparable effect sizes of height loci among populations of European descent.
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Introduction
Heritability of normal variation in human height is estimated to
be ,80%–90% [1–4], much of which is attributed to inherited
factors [5]. Genome-wide association studies (GWAS) and gene-
centric analyses have uncovered over 200 single nucleotide
polymorphisms (SNPs) associated with human height, but these
variants explain only 2,10% of the phenotypic variance [6–12].
Arguing that a large fraction of missing heritability could
potentially stem from the large number of height-related variants
with small effect sizes, a recent study analyzed all genome-wide
SNPs simultaneously and reported that 45% of genetic variation in
height could be explained by common variants [13–15] without
specifying their individual contributions.
The above mentioned GWAS and meta-analysis were based on
large cohorts primarily of European descent sampled from Europe
and North America, although a few have included other ethnicities
[6,12]. In this study, we have assessed the variance explained by
known height-associated loci in a relatively isolated island
population from the Adriatic coast of Croatia with limited
admixture and homogeneous genetic background. Rather than
conducting a discovery study, our purpose was to evaluate whether
the effects of genetic variants uncovered in larger, heterogeneous
study populations are portable to smaller, homogeneous popula-
tions. Specifically, we conducted a GWAS using a panel of 500K
SNPs in a sample of .1300 adults to identify height-associated
variants and estimated variance explained using genetic scores that
combine information from panels of known loci from published
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29475GWAS [6–9,11]. Our study showed that comparable variance
may be explained by previously reported height-associated GWAS
variants, if the comparison population is of European decent, and
that the associated loci and effect sizes of previously identified loci
are comparable in our population.
Methods
Study Population
The study population was derived from a genetic study of
metabolic syndrome [16,17]. Briefly, 1445 men and women were
recruited from Hvar, a middle Dalmatian island on the eastern
Adriatic coast of Croatia. The present day Adriatic islanders are
primarily of Slavic descent, who had emigrated from the mainland
before the 18th century and remained relatively isolated since that
time with attributes of relative homogeneous genetic, cultural and
environmental background [18,19]. Blood samples and anthropo-
metric data were collected in two field seasons of May 2007 and
May 2008. For this study, we used the data on 1304 participants
for whom genome-wide SNP data and height measurements were
available. The study was approved by the Ethics Committee of the
Institute for Anthropological Research in Zagreb, Croatia and the
Institutional Review Board of the University of Cincinnati.
Written informed consent was obtained from all participants.
Genotyping and imputation
Genome-wide SNP genotyping was performed using the
Affymetrix Human SNP Array 5.0 following the manufacture’s
protocol. Genotype calls were determined using the CRLMM
algorithm [20,21] among chips that passed the DM QC call rate
(.0.86). Following further QC filtering of the genotype data
(MAF.0.02, HWE P.0.0001, call rate.95%) using the check.-
marker function implemented in GenABEL [22], we obtained a
cleaned data set of 344,512 SNPs in 1304 samples (565 males and
739 females). On this data set, we performed genotype imputation
using MACH [23] and the reference haplotype data from the
Phase II CEU HapMap [24], yielding genotype data on 2.5
million SNPs.
Genome-wide association analyses
The study sample included 533 unrelated and 771 related
individuals from 238 families. Therefore, two different methods
were used to account for the relatedness – the genomic control
(GC) [25,26] and the measured genotype (MG) approach [27]. In
GC, all samples were treated as unrelated and the inflation factor
(l) was estimated using the median method [28]. In the MG
approach, the kinship matrix was estimated from all autosomal
SNPs instead of pedigree data. To assess the empirical
performance of the two methods, we examined how many of the
previously identified height loci (http://www.genome.gov/
gwastudies/) could be recovered from the top 100 significant
regions (defined as 250 kb on either side of associated SNPs) using
each of these two methods. Standardized height adjusted for age
and gender and their interaction term was used in all analyses. P-
values and effect size estimates assuming additive allelic effect are
reported throughout the manuscript. All statistical analyses were
performed in R v2.12 and the GenABEL package (v.1.6) [22].
Variance explained by identified loci
To assess the overall fitting of previously identified height-
associated loci in our study sample, we estimated the percentage of
variance explained using genetic scores that combine information
from different panels of known loci reported in previous studies.
The unweighted genetic score was computed as an individual’s
number of height-increasing alleles, and the weighted genetic score
was constructed as
P
wiGi; Gi~0, 1 or 2 indicates the number of
reference alleles for specific SNP, wi is the appropriate weight
proportional to previously reported estimates of allelic effect
(measured as beta-coefficient or log transformed odds ratio). The
variance explained (r
2) was then estimated based on a linear
regression model using the scores as predictor and age-, gender-,
and their interaction term adjusted height residuals as outcome.
We estimated and compared the variance explained based on
different panels of height-associated SNPs and their effect size
estimates extracted from published large-scale GWAS, which
included 1) 180 genome-wide significant SNPs reported by Lango
Allen et al. [11], 2) height-associated SNPs reported by the three
GWA studies published in the 2008 May issue of Nature Genetics
[6–8], and 3) 54 height SNPs used by Aulchenko et al [9], which
were derived from the three aforementioned GWAS [6–8].
Results
Height was normally distributed in both males (N=565) and
females (N=739), and males (177.767.5 cm) were significantly
taller than females (164.467.1 cm). Regression analysis showed
that adult height was negatively associated with age in both
genders with a larger age-effect in females. Estimated height
decrease per year in females was 0.239 cm (P=9.05610
255,
r
2=28.0%) and in males was 0.195 cm (P=3.50610
224,
r
2=16.6%, Figure S1).
Genetic scores based on the five published studies are shown in
Table 1. The allele frequencies of the 180 genome-wide significant
SNPs reported by Lango Allen et al. [11] in our samples were
similar to the original report (Figure S2). The correlation of effect
size estimates of these SNPs between our study and the original
report (Stage 1+2) was highly significant although not perfect
(Pearson r=0.472, P=2.32610
211). The effect size estimates of
58 SNPs were in different directions (points in the 2nd and 4th
quadrants in Figure 1). After removing these 58 SNPs, Pearson’s r
increased to 0.851 for the remaining 122 SNPs. However,
heterogeneity test did not show significant differences in estimates
of effect sizes between our study and that of Lango Allen et al.
[11]. Though 12 of the 180 SNPs showed nominally significant
heterogeneity (P,0.05) none survived adjustment for multiple
testing (a full list of these 180 SNPs are provided in the Table S1).
As expected, based on the central limit theorem, the genetic scores
were normally distributed (Figure S3). The weighted genetic score
and adjusted height were significantly (P,1610
216) correlated
(Figure 2). Combining the information from the 180 reference
SNPs the explained variance was 7.94%, which was at the lower
bound of the range of variance explained reported by Lango Allen
et al. – 10.5% (range 7.9–11.2%) [11]. As reflected in Figure 2, the
correlation of genetic score with adjusted height was higher in
females than males with a larger fraction of variance explained
(10.09% vs 5.87% in females and males respectively). The
unweighted genetic scores explained a lower fraction (5.45%) of
the overall variance.
The weighted genetic scores constructed using the SNPs and
effect size estimates reported by the three Nature Genetics studies
[6–8] explained 3,4% of the height variance in our study sample.
The study by Gudbjartsson et al. [6] included an African
American cohort (n=1,148) and the variance explained by the
genetic scores built on the effect sizes estimated from this group
was significantly smaller (P,0.001) than the scores based on the
effect sizes estimated from other groups of European descent
(Icelandic, Dutch or the Europeans Americans), which may reflect
effect size differences among diverse populations.
Height Variability Explained by Known Variants
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al. [7] evaluated their identified SNPs in a height ‘case-control’
sample (the USHT tall-short panel with subjects selected from tails
of the height distribution) and reported allelic effects using odds
ratios (ORs). Our effect size estimates correlated well with the log
transformed ORs (Pearson r=0.639) and the genetic scores
weighted by these log transformed ORs explained even higher
variance (4.62%) than the genetic scores weighted by the beta
value estimates (Table 1).
In addition, we estimated the variance explained by the panel of
54 SNPs analyzed by Aulchenko et al. [9], which were identified by
the three aforementioned GWAS [6–8]. The weighted and
unweighted genetic scores based on these 54 SNPs explained
slightly larger variances than the scores based on any of the
individual studies (Table 1). This study also reported genotypic
effect sizes, which enabled us to construct weighted genotype scores
without the assumption of allelic additivity, though the variance
explained by this genotypic score was similar to that obtained by
weighted genetic scores assuming additive allelic effects.
The reported height-associated SNPs that overlapped across
studies may capture more genuine effects than those obtained
from a single study. Therefore, we tested whether the variance
explained can be increased by including multiple genetic scores as
multi-dimensional predictors. By including the scores with largest
variance explained from each study, the explained variance was
increased to 10.21%.
We also performed genome-wide association analysis in order to
replicate previous findings. As indicated by QQ-plots (Figure S4),
both GC and MG appropriately controlled type I error rates. The
genome-wide single-locus test statistics were inflated compared to
the null distribution with an estimated inflation factor l=1.41.As
expected this estimate was the highest among all metabolic traits we
studied (unpublished data) since the inflation factor is larger for traits
with higher heritability and substantial inflation is likely attributable
to the large number of SNPs associated with height [29].
The P-values obtained by GC and MG were highly correlated
(Pearson’s r=0.766). Interestingly, the GC method recovered 9
previously known loci (Table 2 and Figure S5) compared to 4
recovered by the MG approach, three of which were in the 9 GC
regions. Due to our limited sample size, however, none of these
loci reached genome-wide significance (P,5610
28). The 9 GC
regions include several well known height loci, including EFEMP1,
UQCC and HMGA2. Of particular interest is the UQCC locus
(also known as the GDF5-UQCC region; Figure 3A). This region
encompasses approximately 850 kb, covering more than 20 genes,
and has a relatively low recombination rate. The most significant
signal was observed on SNP rs6058227 (P=8.21610
26); the
minor allele (T) was associated with an average increase of height
1.93 cm. Re-analysis of the region conditional on rs6058227 failed
to completely eliminate the signals of the other SNPs, suggesting
the possibility of multiple causal variants within the region
(Figure 3B). Similar evidence for allelic heterogeneity was also
reported by Lango Allen et al., and the presence of multiple
functional variants could be a potential source of missing
heritability [11].
Discussion
We presented an estimation of variance explained by previously
reported height-associated loci in a relatively isolated population
based on a genome-wide scan of 2.5 M genotyped and imputed
SNPs in 1304 individuals. Given our relatively small sample size,
Table 1. Genetic scores based on different reference studies.
Reference studies(Authors) Data Table
# # SNPs
$ Reference effect sizes
&
reff
* Variance explained (%)
Source Sample size Unweighted Weighted
Nature 467:832-8 [11] Suppl Table 1 180 Stage 1 133653 0.455 5.45 7.79
Lango Allelen et al. Stage 2 50074 0.497 5.45 7.95
Stage 1+2 183727 0.472 5.45 7.94
Females 110489 0.461 5.45 7.87
Males 73238 0.486 5.45 7.80
Nat Genet 40:609-15 [6] Table 1 and 2 57 Iceland 25174 0.523 3.35 3.58
Gudbjartsson et al. Holland 2876 0.550 3.35 3.72
US Cau 1770 0.448 2.62 2.69
US Afr 1148 0.199 0.81 1.01
Nat Genet 40:584-91 [7] Table 1 29 Meta 15821 0.492 3.50 3.48
Lettre et al. Follow-up 19990 0.577 1.43 3.38
Combined 35811 0.539 3.50 3.85
USHT* 2189 0.639 3.19 4.62
Nat Genet 40: 575-83 [8] Table 1 20 Female na 0.657 3.18 3.20
Weedon et al. Male na 0.732 3.18 3.77
Eur J Hum Genet 17:1070-5 Suppl Table 1 54 Add, single 5748 0.608 4.75 4.83
Aulchenko et al. Genotype 5748 - 4.07 4.28
#The table number in the reference study, from where the list of height-associated SNPs and their effect size estimates were extracted to build the genetic scores.
$The number of height-associated SNPs reported by the reference study.
&Individual reference studies report multiple effect sizes estimated from multiple sources with different sample sizes. Based on these estimates, different genetic scores
can be constructed.
*The Pearson correlation between the effect sizes extracted from the original report and estimated from our samples.
doi:10.1371/journal.pone.0029475.t001
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evaluate whether height-associated SNPs identified by GWA
studies in large population cohorts share similar effects in an
isolated and homogeneous population.
We evaluated the percentage of variance explained by genetic
scores based on previously reported panels of height-associated
SNPs and their effect size estimates. Under the assumption of
additive effect between loci, the weighted genetic score captures
the majority of genetic effects at multiple loci. The corresponding
explained variance can be used as an indicator of the overall
agreement of the effect size estimates between reference studies
(from which the effect sizes/weights were developed) and our
current study. The results indicate that a comparable fraction of
variance can be explained in our samples if the genetic score was
constructed from a population of European descent. In our sample
the variance explained by the 180 height-associated SNPs reported
by Lango Allen et al. [11] was 7.94%, which was within the range
(7.9–11.2%) of the original report, though at the lower end. The
higher percentage of variance explained by the weighted scores
compared to the unweighted scores (5.45%) also suggested that the
effect sizes estimated from meta-analysis of multiple cohorts of
European descent can be applied to our relatively isolated
population, which is also of European descent. At the individual
SNP level, we did not detect significant differences in effect size
estimates between our study and the reference study. Altogether,
these observations indicate similar genetic architecture (i.e.
associated loci and their effect sizes) of height in the same
continental populations.
Using the SNPs reported by the three Nature Genetics studies
[6–8], the percentages of variance explained were around 3,4%,
which were within the range of the original reports. We also found
that the log transformed odds ratios estimated from extreme
‘‘case/control’’ samples [7] provided accurate estimates of real
effect sizes, illustrated by the larger variance explained compared
to scores using beta coefficients estimated from unascertained
population-based cohorts with larger sample sizes. The signifi-
cantly lower variance explained using the genetic scores based on
effect size estimates from US African samples demonstrated
substantially different effect size estimates between distantly related
populations. Since our sampled individuals contained familial
relatedness, we tested two methods to account for relatedness. The
measured genotype (MG) approach uses a mixed model to
quantify the polygenic effect and the fixed effect (association)
simultaneously and is a robust and powerful method for the
analysis of quantitative traits in related samples [30]. Genomic
control (GC) is a simpler and computationally efficient method
Figure 1. Effect size estimates of the 180 height SNPs were correlated between our study and the reference study by Lango Allele
et al.
doi:10.1371/journal.pone.0029475.g001
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introduced by population stratification [26,28] and has been
recently applied to account for relatedness in association tests [31].
The GC method corrects the false positive rate by adjusting test
statistics using a uniform inflation factor and it ranks significant
findings in the same order as conventional association tests that do
not account for relatedness.
Our results indicate that the empirical performance of the GC
method was better than the MG approach by recovering a larger
number of previously-identified height loci among the top
ranking regions. This implied that the P-values reported by GC
or association tests ignoring relatedness may better reflect the real
order of significance than the complex approach of MG. Recent
simulation studies indicate that GC or conventional tests are
appropriate methods to study genetic association in randomly
ascertained, moderate-size pedigrees for both quantitative [32]
and qualitative traits [33]. However, for polygenic traits with high
heritability (such as height), GC may be over-conservative since
all SNPs, a substantial fraction of which are truly associated with
the trait, are used to estimate the inflation factor [29,32]. The
inflation factor (l=1.41) for height observed in current analysis
was the highest among all traits we studied in the same
population sample (data not shown). This high estimate is likely
explained by high heritability and the large number of associated
SNPs rather than by population stratification or relatedness;
therefore rendering the reported association P-values (Table 2)
conservative.
Of the 9 height-associated loci described in Table 2, several
were among the top of the significant lists in multiple GWAS; for
example, HMGA2 [34] and GDF5-UQCC [35] were the first two
identified height loci and were widely replicated in multiple studies
[6–8]. The EFEMP1 locus was first reported by Weedon et al. [8]
and Gudbjartsson et al. [6] and was subsequently replicated in
Australians of European descent [36] and Asian populations [37–
39]. Four other gene regions, L3MBTL3 [6,11], CRADD [6,8],
JAZF1 [10,40], and ANAPC13 [8] were also reported in
European GWA studies. Of note is the GRIA1 locus, which was
previously reported in a GWAS in another Adriatic island
population [41]. Though the IGF1 (insulin-like growth factor 1)
pathway is integral to growth and mutations in IGF1 usually result
in growth retardation [42], candidate gene studies testing for
associations between common variants of IGF1 and height
variation have been inconclusive [43–45]. Two recent GWAS
[38,39] have, however, confirmed IGF1 as a height-associated
locus in Asian populations. However, this locus has not been
identified in European GWA studies with even much larger
sample sizes, suggesting weak statistical powers due to differences
in allele frequencies or linkage disequilibrium patterns between
populations.
As in the study by Lango Allen et al. [11], through
conditional analysis we found evidence supporting allelic
heterogeneity in many height-associated regions. In the
G D F 5 - U Q C Cr e g i o n ,f o re x a m p l e ,o u rm o s ts i g n i f i c a n tS N P
(rs6058227) was not in close linkage disequilibrium with six
index SNPs reported in previous GWA studies and analysis
conditional on rs6058227 could not eliminate the significances
of the adjacent SNPs in that region. These all are highly
suggestive of multiple effective SNPs in this region. This
Figure 2. Correlation between height and weighted genetic scores in males and females.
doi:10.1371/journal.pone.0029475.g002
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a common feature of polygenic loci and identification of
additional functional variants beyond the lead SNPs may
increase the proportion of variance explained for complex traits
[11,46].
In summary, we have evaluated the portability of height-
related loci and their estimated effect sizes reported in large
cohorts to an isolated population with a homogeneous genetic
background. We found proportions of explained height variability
were comparable to multiple reference GWAS in populations of
Table 2. Nine replicated height-associated loci identified by GC approach.
No Regions
# Index SNPs
$
GWAS SNPs
& Genes
chr start end length rs_id MAF P-value
1
* 2 55822780 56080130 257351 rs6730839 0.25 1.53610
26 rs3791679 EFEMP1
rs3791675
2
* 20 33267822 34124695 856874 rs6058227 0.13 8.21610
26 rs6060369 UQCC
rs6088813
rs6060373
rs2236164
rs6088792
3 5 152756659 153018678 262020 rs7737904 0.03 2.12610
25 rs12658202 GRIA1
4
* 12 64588210 64702663 114454 rs1042725 0.49 5.21610
25 rs8756 HMGA2
rs1042725
5 6 130271009 130327351 56343 rs10457532 0.24 1.22610
24 rs6899976 L3MBTL3
rs6569648
6 12 92723646 92899954 176309 rs10444517 0.06 1.24610
24 rs11107116 CRADD
rs3825199
7 3 135631761 135778576 146816 rs9866359 0.14 1.44610
24 rs10935120 ANAPC13
8 7 28128599 28246163 117565 rs849315 0.12 1.62610
24 rs1635852 JAZF1
rs849141
9 12 101541161 101630322 89162 rs833718 0.50 1.94610
24 rs5742692 IGF1
rs1520223
#Each significant region was selected starting with a ‘‘seed’’ SNP (P,5610
24) and was extended to adjacent SNPs with (P,5610
23) within 25 kb. The chromosomal
positions were based on NCBI Genome Build 36.3.
$Index SNPs were the most significant SNP observed in each region.
&GWAS SNPs were known height-associated SNPs within or near (,250 kb) the region (extracted from GWA catalog: http://www.genome.gov/gwastudies/).
*These three regions were also in the top 100 regions identified by MG approach.
doi:10.1371/journal.pone.0029475.t002
Figure 3. LocusZoom plot of the GDF5-UQCC region before (A) and after (B) conditioning. The most significant SNP was rs17092784 after
conditioning on rs6058227.
doi:10.1371/journal.pone.0029475.g003
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tecture and comparable effect sizes of height loci among
populations of European descent.
Supporting Information
Figure S1 Correlation of height with age in males and
females.
(TIF)
Figure S2 Minor allele frequencies of the 180 height-
associated SNPs were highly correlated between our
study and the reference study by Lango Allen et al [11].
(TIF)
Figure S3 Genetic scores follow normal distribution.
(TIF)
Figure S4 QQ plot of GC (A) and MG (B) association
test.
(TIF)
Figure S5 Manhattan plot (the red bars indicated the
nine replicated GWA regions).
(TIF)
Table S1 Frequencies and effect sizes of the 180 height-
associated SNPs reported by Lango Allelen et al. [Nature
467 (7317): 832-8].
(PDF)
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